TearSolutions: Naturally Treating Dry Eye (225)

Episode 25 July 04, 2022 00:23:20
TearSolutions: Naturally Treating Dry Eye (225)
Innovation4Alpha
TearSolutions: Naturally Treating Dry Eye (225)

Jul 04 2022 | 00:23:20

/

Show Notes

TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and relief of dry eye symptoms with a best-in-class safety and comfort profile. This was all proven in their first-in-human clinical trial which has led to formal written FDA alignment on our clinical and regulatory path to an unrestricted general Dry Eye indication (which is the same path a dry eye drug called Xiidra took, which sold to Novartis for $5.3B). 

The company is raising capital to get Lacripep back into the clinic for the first of two Phase III trials.

Other Episodes

Episode 23

June 11, 2022 00:41:34
Episode Cover

From Ukraine to Uganda - Project Cure Delivers Critical Medical Equipment and Supplies (223)

Project Cure CEO Douglas Jackson, PhD shares the mission of Project Cure in a wide ranging discussion that illustrates the incredible supply chain expertise...

Listen

Episode 1

July 17, 2024 00:31:16
Episode Cover

Lessons Learned as a Surgeon & Fund Investor

In this episode, Ryan Khanna, MD, MBA co-hosts a discussion with Robert Eastlack who runs a premier surgical spine practice in San Diego, CA...

Listen

Episode 18

August 30, 2021 00:42:32
Episode Cover

Julie Anderson of Cambia Grove (018)

Julie Anderson is the Director of Strategic Initiatives at Cambia Grove and a healthcare veteran.Cambia Grove is a health care innovation hub focused on...

Listen